Reversible hemiparesis associated with the use of topiramate

Seizure

Volumn 11, Issue 7, 2002, Pages 460-463

  Patel, Hema ^a   Asconapé, Jorge J ^a   Garg, Bhuwan P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic medications; Epilepsy; Hemiparesis; Topiramate; Topiramate toxicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; GADOLINIUM; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ANOREXIA; APATHY; ARTICLE; ATAXIA; CASE REPORT; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DYSPHAGIA; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FATIGUE; FOCAL EPILEPSY; HEMIPARESIS; HUMAN; INTRACTABLE EPILEPSY; LANGUAGE DISABILITY; MALE; MUSCLE WEAKNESS; NOCTURNAL ENURESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY; WEIGHT REDUCTION;

EID: 0036797040     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0641     Document Type: Article

References (10)

1. Shank, R. P., Gardocki, J. F., Streeter, A. J. and Maryanoff, B. E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanism of action. Epilepsia 2000; 41 (Suppl. 1): S3-S9.
2. Reife, R., Pledger, G. and Wu, S. -C. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000; 41 (Suppl. 1): S66-S71.
3. Montouris, G. D., Biton, V, Rosenfeld, W. E. and the Topiramate YTC/YTCE study group, Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Epilepsia 2000; 41 (Suppl. 1): S77-S81.
4. Ritter, F., Glauser, T. A., Elterman, R. D., Wyllie, E. and the Topiramate YP study group, Effectiveness, tolerability and safety of topiramate in children with partial onset seizures. Epilepsia 2000; 41 (Suppl.1): S82-S85.
5. Elterman, R. D., Glauser, T. A., Wyllie, E., Reife, R., Wu, S. C., Pledger, G. and the topiramate YP study group, A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999; 52: 1338-1344.
6. Stephen, L. J., Maxwell, J. E. and Brodie, M. J. Drug points: transient hemiparesis with topiramate. BMJ 1999; 318: 845.
7. Osorio, I., Burnstine, T. H., Remler, B., Manon-Espaillat, R. and Reed, R. C. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia 1989; 30: 230-234.
8. Shields, D. W. and Saslow, E. Myoclonic, tonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487-1489.
9. Etinger, A. B., Bernal, O. G., Andriola, M. R. et al. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 1999; 40: 1159-1162.
10. Eckardt, K. M. and Steinhoff, B. J. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998; 39: 671-674.